14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.78 $7.64 Thursday, 25th Apr 2024 FATE stock ended at $3.87. This is 10.00% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 9.79% from a day low at $3.78 to a day high of $4.15.
90 days $3.78 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Apr 25, 2024 $4.14 $4.15 $3.78 $3.87 3 566 110
Apr 24, 2024 $4.59 $4.66 $4.17 $4.30 2 040 039
Apr 23, 2024 $4.79 $5.02 $4.49 $4.54 3 992 798
Apr 22, 2024 $4.84 $4.92 $4.67 $4.78 1 099 076
Apr 19, 2024 $4.95 $5.11 $4.70 $4.79 2 479 946
Apr 18, 2024 $5.27 $5.35 $4.98 $5.04 2 329 053
Apr 17, 2024 $5.50 $5.63 $5.21 $5.27 2 081 550
Apr 16, 2024 $5.53 $5.74 $5.32 $5.38 2 776 305
Apr 15, 2024 $5.80 $5.95 $5.39 $5.64 2 687 359
Apr 12, 2024 $5.95 $5.95 $5.67 $5.77 1 806 793
Apr 11, 2024 $6.33 $6.37 $5.90 $5.95 1 808 141
Apr 10, 2024 $6.38 $6.48 $6.23 $6.27 2 379 701
Apr 09, 2024 $6.69 $6.81 $6.54 $6.76 1 615 668
Apr 08, 2024 $6.98 $6.98 $6.42 $6.71 2 078 916
Apr 05, 2024 $6.90 $7.14 $6.80 $6.92 1 174 520
Apr 04, 2024 $7.18 $7.35 $6.93 $6.97 1 161 294
Apr 03, 2024 $6.78 $7.29 $6.65 $7.01 2 610 393
Apr 02, 2024 $6.84 $7.08 $6.75 $6.80 1 835 153
Apr 01, 2024 $7.33 $7.33 $6.89 $7.08 1 825 590
Mar 28, 2024 $7.27 $7.64 $7.23 $7.34 2 620 063
Mar 27, 2024 $6.97 $7.37 $6.77 $7.34 2 073 750
Mar 26, 2024 $7.03 $7.12 $6.68 $6.86 2 338 810
Mar 25, 2024 $6.57 $7.01 $6.54 $6.87 1 979 741
Mar 22, 2024 $7.47 $7.59 $6.61 $6.61 1 987 092
Mar 21, 2024 $7.51 $7.70 $7.19 $7.43 1 944 703
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT